• Home
  • Latest
  • Fortune 500
  • Finance
  • Tech
  • Leadership
  • Lifestyle
  • Rankings
  • Multimedia
Right Arrow Button IconLeft Arrow Button IconHome
Right Arrow Button IconPfizer

Pfizer

Page 25 of 37
Why Wall Street is ‘signaling caution’ for your stock portfolio in 2021
NewslettersWhy Wall Street is ‘signaling caution’ for your stock portfolio in 2021
By Bernhard WarnerDecember 15, 2020
US-Vaccine-Rollout
HealthPhotos: U.S. health workers begin receiving COVID-19 vaccine
By Alex Scimecca and Mia DiehlDecember 14, 2020
Photo of AstraZeneca CEO Pascal Soriot
FinanceWhy shareholders had a severe adverse reaction to AstraZeneca’s Alexion deal
By Jeremy KahnDecember 14, 2020
COVID vaccines are coming—but it might be too late for the housing market
NewslettersCOVID vaccines are coming—but it might be too late for the housing market
By Bernhard WarnerDecember 14, 2020
Side effects, dosage, price, and more: Everything you need to know about Pfizer’s COVID-19 vaccine
HealthSide effects, dosage, price, and more: Everything you need to know about Pfizer’s COVID-19 vaccine
By David Z. MorrisDecember 10, 2020
IPO Thursday: What you need to know ahead of Airbnb’s big debut
NewslettersIPO Thursday: What you need to know ahead of Airbnb’s big debut
By Bernhard WarnerDecember 10, 2020
U.K. warns people with history of severe allergic reactions not to get the COVID-19 vaccine
HealthU.K. warns people with history of severe allergic reactions not to get the COVID-19 vaccine
By Naomi Kresge, Emily Ashton and BloombergDecember 9, 2020
Investors turn bullish on vaccine hopes, IPO mania, and stimulus talks
NewslettersInvestors turn bullish on vaccine hopes, IPO mania, and stimulus talks
By Bernhard WarnerDecember 9, 2020
Britain COVID-19 Vaccine
HealthPhotos: First COVID-19 vaccines begin in U.K.
By Sy Mukherjee and Alex ScimeccaDecember 8, 2020
Good news: the COVID vaccine is here! The not so good: markets are unimpressed
NewslettersGood news: the COVID vaccine is here! The not so good: markets are unimpressed
By Bernhard WarnerDecember 8, 2020
Who gets first dibs on a COVID-19 vaccine? The U.K.’s historic rollout today reveals who gets precedence
HealthWho gets first dibs on a COVID-19 vaccine? The U.K.’s historic rollout today reveals who gets precedence
By Katherine DunnDecember 8, 2020
Britons will roll up their sleeves on Tuesday for a COVID vaccine jab as the world anxiously watches
HealthBritons will roll up their sleeves on Tuesday for a COVID vaccine jab as the world anxiously watches
By James Paton, Suzi Ring and BloombergDecember 7, 2020
The global rally stalls out, but Goldman Sachs is doubling down on value stocks
NewslettersThe global rally stalls out, but Goldman Sachs is doubling down on value stocks
By Bernhard WarnerDecember 7, 2020
Coronavirus
HealthThe science behind the leading COVID vaccines will lead to faster manufacturing
By Sy MukherjeeDecember 5, 2020
Crystal Ball 2021: Predictions for the economy, politics, technology, and more
MagazineCrystal Ball 2021: Predictions for the economy, politics, technology, and more
By Fortune StaffDecember 1, 2020
1...
  • 23
  • 24
  • 25
  • 26
  • 27
...37
Most Popular
Economy
The U.S. government is spending $88 billion a month in interest on national debt—equal to spending on defense and education combinedplaceholder alt text
By Fortune EditorsApril 9, 2026
Energy
2 years ago, Saudi Arabia quietly canceled the ‘petrodollar’ deal with America that wired the world economy for 50 years. Then war broke out in Iranplaceholder alt text
By Fortune EditorsApril 7, 2026
Economy
The U.S. had a national debt ‘home run’ in its grasp, says Jamie Dimon. But the government did nothing, and now its best option is crisis managementplaceholder alt text
By Fortune EditorsApril 8, 2026
Fortune Secondary Logo
Rankings
  • 100 Best Companies
  • Fortune 500
  • Global 500
  • Fortune 500 Europe
  • Most Powerful Women
  • Future 50
  • World’s Most Admired Companies
  • See All Rankings
Sections
  • Finance
  • Fortune Crypto
  • Features
  • Leadership
  • Health
  • Commentary
  • Success
  • Retail
  • Mpw
  • Tech
  • Lifestyle
  • CEO Initiative
  • Asia
  • Politics
  • Conferences
  • Europe
  • Newsletters
  • Personal Finance
  • Environment
  • Magazine
  • Education
Customer Support
  • Frequently Asked Questions
  • Customer Service Portal
  • Privacy Policy
  • Terms Of Use
  • Single Issues For Purchase
  • International Print
Commercial Services
  • Advertising
  • Fortune Brand Studio
  • Fortune Analytics
  • Fortune Conferences
  • Business Development
  • Group Subscriptions
About Us
  • About Us
  • Editorial Calendar
  • Press Center
  • Work At Fortune
  • Diversity And Inclusion
  • Terms And Conditions
  • Site Map
  • About Us
  • Editorial Calendar
  • Press Center
  • Work At Fortune
  • Diversity And Inclusion
  • Terms And Conditions
  • Site Map
  • Facebook icon
  • Twitter icon
  • LinkedIn icon
  • Instagram icon
  • Pinterest icon

© 2026 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
FORTUNE is a trademark of Fortune Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.